Bode-CARES – Complete, Turnkey COVID-19 Testing Solution
Bode offers a turn-key solution for our clients including collections, automated software reporting, and high-quality testing. Contact Bode to inquire about our COVID-19 Testing Services: email@example.com
Bode can supply collection materials including barcode labels, swabs and transport media to the testing site in advance of the testing. Bode’s swabs and transport media are widely used for the collection, preservation, and transportation of anterior nares pathogen specimens. The swabs and transport media are FDA approved and meet all industry requirements for sample collection and transport. The swab will have a breakpoint which will allow for the sample to transferred to viral transport media. Samples should be stored at 2-8 Celsius for up to 72 hours after collection. Appropriate biological transport packaging and shipping materials can also be provided.
Electroinic Patient Portal
Bode offers an easy-to-use patient portal for our Bode-CARES clients.The Bode-CARES portal manages test requisitions and issues reports through software developed and deployed by Bode. All personal identifying information (PII) and reports will be encrypted. The handling and security of the data is HIPAA compliant. The Bode-CARES electronic test requisition includes all information required by USACE.
Patients can pre-register in the portal to capture all of their information, including insurance information. Once in the system, administrators can call-up the individual’s records and simply assign a barcode to the sample so that paperwork and record keeping is minimized during the collection.
Scheduling (if desired)
Bode offers an online scheduling platform to allow members to schedule their own appointments while maintaining control of available testing days. This allows the administration to control daily sample numbers and arranging the testing of individuals within the recommended time frame following exposure. It also allows the administrative to make and cancel appointments as needed. Daily collections schedules are provided to the administration as well as the collection staff.
Transport – Courier Service – Same Day Delivery
Bode will provide cold packs, boxes and FedEx labels for overnight shipping to the laboratory or a courier service. Transportation supplies and costs are included in the price for testing.
Lab Testing - High Capacity
Bode can test nasopharyngeal, oropharyngeal, or nasal (anterior nares) swabs collected on a nylon flocked swab transported in a universal transport media.
Bode will provide RT-PCR testing for the SARS-CoV-2 virus as requested by a medical provider. Bode-CARES COVID-19 testing is a molecular diagnostic test for the SARS-CoV-2 virus. The test will indicate whether SARS-CoV-2 virus was detected in a specimen, was not detected, or was inconclusive for detection.
The test methods used at Bode currently include the isolation of SARS-CoV-2 genomic RNA using the ThermoFisher Scientific MagMAX Viral/Pathogen II Nucleic Acid Isolation Kit and real-time reverse transcription polymerase chain reaction (RT-PCR) detection of the ORF1a, N, and S genes using the ThermoFisher TaqPathTM COVID-19 Combo Kit.
+Lab Testing – Pooling
Bode will have pooled testing available online in early January. The implementation of pooled testing significantly increases the capacity of testing, while reducing costs. By using this approach, pools of four (4) individual samples will be tested together. In the event that the result in a pool is positive, the client and individuals will be notified of suspected positive samples within the quoted turnaround time, and the individual samples will be re-run to determine which individual(s) is positive. Those individual samples would then be confirmed within the next 24 hours.
+Service expect to be available January 2021
Bode will report all results via the Bode-CARES patient portal to the requesting physician as soon as samples are through the laboratory testing process. Client will provide a physician to approve and release test results. Release is managed through the Bode-CARES patient portal. Upon release, individual patients will receive email notification that their results are ready. Results will also be reported to the appropriate department of health. Results will be reported to the Department of Health.
Bode can provide 7-day customer support to the university during this effort. Bode’s support team can address questions or concerns from individual patients or university administrators. Remote technical support has been available and responsive 7-days per week.
If the individual has a positive test result (SARS-CoV-2 was detected in the specimen), it is very likely that the patient has COVID-19. The individual’s physician should work with the individual to determine the best course of action.
If SARS-CoV-2 was not detected in the specimen, the individual most likely was not infected at the time the specimen was collected.
The RT-PCR assay utilized in this program is the most sensitive method of detection available. It only determines whether the individual is positive or negative for the virus at the time the test is taken. However, detection of SARS-CoV-2 RNA may be affected by specimen collection and transport methods and individual patient characteristics (e.g. stage of infection).
COVID-19 Resources - General
COVID-19 Guidelines for Workplaces
COVID-19 Guidelines for First Responders
- CDC - What Law Enforcement Personnel Need to Know about COVID-19
- CDC - FAQs for Law Enforcement
- CDC - Interim Guidance for Implementing Safety Practices for Critical Infrastructure Workers Who May Have Had Exposure to a Person with Suspected or Confirmed COVID-19
- CDC - CDC Guidance on Management of COVID-19 in Correctional and Detention Facilities